Suzhou Aijie Biotechnology Co., Ltd., established on 2001-12-24, Business scope includes research and development,Production Class II6840In vitro diagnostic reagents,And sell the products produced by the company.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Part of Beijing Wanger Biotechnology Co. Ltd., Beijing Kwinbon Biotechnology Co., Ltd. is a company headquartered in Changping District, China, that operates as testing laboratory specialized in research and development of rapid detection instrument and immunodiagnostic reagents for food safety.

Virginia Tech Intellectual Properties, Inc. handles, protects and licenses technologies developed by the faculty, staff and students. It facilitates the licensing of technology to companies, encourages new faculty startup ventures, works with publishers and distributors of software, and supports the transfer of research and knowledge to other universities, research institutes and companies. The company was founded in 1985 and is headquartered in Blacksburg, VA.

UBI is a privately held multinational biopharmaceutical company dedicated to the discovery, development and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases. their product pipeline is filled with their new line of synthetic peptide-based biologicals for the treatment and prevention of Alzheimer’s Disease, AIDS, Autoimmune diseases, and Allergy, along with a portfolio of Animal health diseases. These products are based on their proprietary designer peptides, vaccine formulation systems, and methods to manufacture therapeutic monoclonal antibodies.

BioTeSys GmbH provides services in the area of biological and chemical analysis. It serves the food, cosmetics, and medical devices area. The firm’s products include surface coating, a clean room technology for cell culture applications, multivitamin, a non invasive method for determining intracellular micronutrient concentrations, biomining, a tool that makes experimental results accessible, lar test system for determining biological function, fluoroscan, a procedure to analyze living system and screening of test groups, histology, a technique to detect cellular alterations and damage in tissue, and clinical studies to assess the bioactive potential of active agents. The company was founded in 1999 and is headquartered in Esslingen, Germany.

Brevitest Technologies is a developer of a point-of-care medical device to assist enzyme immunoassays for early-stage detection of diseases. Its portable and automated analyzer performs enzyme-linked immunosorbent assays in less than ten minutes using customizable disposable cartridges suitable for detecting and quantifying peptides, proteins, antibodies, and hormones in biological samples that enable medical researchers to replace painful, time-consuming laboratory-based diagnostics and detect abnormalities in enzymes in a cost-effective manner.

DiabetOmics is a medical diagnostics company that provides non-invasive assessment and management of personalized health and diabetes risk. Its mission is to advance the health and wellbeing of people with, or at risk for, diabetes through simple, cost-effective, and easily accessible diabetes care. Their goal is to develop and provide point-of-care testing capabilities that are especially useful in alleviating the substantial economic and public health burden of diabetes. DiabetOmics was founded in 2008 and is headquartered in Beaverton, Oregon.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Bruker Optics is a company that provides manufacturing and distributes research services on infrared (IR), near-infrared (NIR), FT-Raman, and dispersive Raman Spectroscopy. Industry, government, and academia use these products for research and development, quality control, process analysis, and pharmaceutical analysis for life science, pharmaceutical analysis, food, and agricultural analysis. The infrared part of the electromagnetic spectrum is used in infrared spectroscopy, a type of absorption spectroscopy.

iStat Biomedical Co., Ltd. develops and manufactures gene methylation assay products for the early detection of cervical, oral and bladder cancers. Its products include Cervi-M, Oral-M and instruments & reagents. The company was founded on April 15, 1994 and is headquartered in New Taipei City. Taiwan.

Manufactures insulin and industrial enzymes

Glaxo Group Ltd. operates through its subsidiary Glaxo Laboratories Ltd. that engages in the production of food products for infants such as Ostermilk, Complan, Casilan, Farex. Glaxo Group Ltd. was formerly known as Glaxo Laboratories Ltd. and changed its name to Glaxo Group Ltd. in 1962. The company is based in Brentford, United Kingdom. Glaxo Group Ltd. operates as a subsidiary of Glaxosmithkline plc.

Bruker Optik Holding GmbH, part of Bruker Corp., is a company headquartered in Ettlingen, Germany, that manufactures optical and photographic instruments and devices. Roland Harig, Urban Faeh and Marc Beisel are the current co-CEOs of the firm.

RD-Biotech SAS offers solutions in genomics, immunology and cell engineering, as part of research and development programs. It enables biological reagents and tools such as hybridomas, cell lines, vectors etc in parallel with enhancement of protocols and methods. The firm also includes monoclonal antibodies, recombinant proteins, cell lines, plasmids and nucleic acid preparation service. RD-Biotech was founded in 2002 and is headquartered in Besancon, France.

Fannin Innovation Studio is an early-stage life science development group focused on commercializing innovation developed in the Texas Medical Center institutions. Fannin provides its startups with central office space, seed capital, and a vast network of resources. To address the root cause of Houston’s commercialization gap, the company works directly with the city’s top-tier, higher education institutions to recruit aspiring entrepreneurs to join its apprenticeship program which provides on-the-job training to collaboratively lead its portfolio companies from innovation to commercialization.

Plexense, Inc. engages in the development and production of rapid and cost-effective immunoassay platform for clinical, food and life sciences testing. The company was founded by Kim Gi-Beom on March 14, 2012 and is headquartered in Yongin-si, South Korea.